HF
PYXS icon

HRT Financial’s Pyxis Oncology PYXS Stock Holding History

HRT Financial’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,649
Closed -$45K – 4551
2025
Q4 		$45K Buy
39,649
+24,251
+157% +$85.5K ﹤0.01% 2889
2025
Q3 		$34K Sell
15,398
-35,270
-70% -$50.8K ﹤0.01% 2641
2025
Q2 		$55K Buy
+50,668
New +$57.1K ﹤0.01% 2296
2024
Q2 		– Sell
-139,142
Closed -$592K – 2927
2024
Q1 		$592K Buy
+139,142
New +$585K ﹤0.01% 1174
2023
Q2 		– Sell
-69,782
Closed -$279K – 3108
2023
Q1 		$279K Buy
+69,782
New +$139K ﹤0.01% 1750

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial's PYXS Position: Q1 2026 in Review

HRT Financial sold out of Pyxis Oncology (PYXS) in Q1 2026, closing a stake of 39,649 shares — an estimated $45K sold.

HRT Financial first reported a position in PYXS in Q1 2023 and held it in 5 quarters. The position peaked at $592K in Q1 2024. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • HRT Financial reported no remaining Pyxis Oncology position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 39,649 Pyxis Oncology shares in Q1 2026, an estimated $45K.
  • HRT Financial first reported a position in Pyxis Oncology in Q1 2023 and held it in 5 quarters.
  • HRT Financial's Pyxis Oncology position peaked at $592K in Q1 2024.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.